Hemoperfusion and intravenous immunoglobulins for refractory gastrointestinal involvement in pediatric Henoch-Schönlein purpura: a single-center retrospective cohort study

BACKGROUND: Henoch-Schönlein purpura (HSP) with refractory gastrointestinal (GI) symptoms is always difficult to handle because of its resistance to supportive therapies and glucocorticoid. This study aimed to evaluate the efficacy of hemoperfusion (HP) and intravenous immunoglobulins (IVIG) therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaolu, Che, Ruochen, Xu, Haisheng, Ding, Guixia, Zhao, Fei, Huang, Songming, Zhang, Aihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716741/
https://www.ncbi.nlm.nih.gov/pubmed/36460986
http://dx.doi.org/10.1186/s12887-022-03709-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716741/
https://www.ncbi.nlm.nih.gov/pubmed/36460986
http://dx.doi.org/10.1186/s12887-022-03709-0

Ejemplares similares